These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 23865807)

  • 21. Impact of bilayer lipid composition on the structure and topology of the transmembrane amyloid precursor C99 protein.
    Song Y; Mittendorf KF; Lu Z; Sanders CR
    J Am Chem Soc; 2014 Mar; 136(11):4093-6. PubMed ID: 24564538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dcf1 alleviates C99-mediated deficits in drosophila by reducing the cleavage of C99.
    Li W; Li Y; Gan L; Ma F; Zhang S; Wen T
    Biochem Biophys Res Commun; 2020 Sep; 530(2):410-417. PubMed ID: 32540098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonspecificity of binding of gamma-secretase modulators to the amyloid precursor protein.
    Beel AJ; Barrett P; Schnier PD; Hitchcock SA; Bagal D; Sanders CR; Jordan JB
    Biochemistry; 2009 Dec; 48(50):11837-9. PubMed ID: 19928774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The GxxxG motif in the transmembrane domain of AbetaPP plays an essential role in the interaction of CTF beta with the gamma-secretase complex and the formation of amyloid-beta.
    Mao G; Tan J; Cui MZ; Chui D; Xu X
    J Alzheimers Dis; 2009; 18(1):167-76. PubMed ID: 19625750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific Binding of Cholesterol to the Amyloid Precursor Protein: Structure of the Complex and Driving Forces Characterized in Molecular Detail.
    Nierzwicki Ł; Czub J
    J Phys Chem Lett; 2015 Mar; 6(5):784-90. PubMed ID: 26262653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NSAID-based γ-secretase modulators do not bind to the amyloid-β polypeptide.
    Barrett PJ; Sanders CR; Kaufman SA; Michelsen K; Jordan JB
    Biochemistry; 2011 Nov; 50(47):10328-42. PubMed ID: 21995415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homophilic interactions of the amyloid precursor protein (APP) ectodomain are regulated by the loop region and affect beta-secretase cleavage of APP.
    Kaden D; Munter LM; Joshi M; Treiber C; Weise C; Bethge T; Voigt P; Schaefer M; Beyermann M; Reif B; Multhaup G
    J Biol Chem; 2008 Mar; 283(11):7271-9. PubMed ID: 18182389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulating Hinge Flexibility in the APP Transmembrane Domain Alters γ-Secretase Cleavage.
    Götz A; Mylonas N; Högel P; Silber M; Heinel H; Menig S; Vogel A; Feyrer H; Huster D; Luy B; Langosch D; Scharnagl C; Muhle-Goll C; Kamp F; Steiner H
    Biophys J; 2019 Jun; 116(11):2103-2120. PubMed ID: 31130234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and biochemical differences between the Notch and the amyloid precursor protein transmembrane domains.
    Deatherage CL; Lu Z; Kroncke BM; Ma S; Smith JA; Voehler MW; McFeeters RL; Sanders CR
    Sci Adv; 2017 Apr; 3(4):e1602794. PubMed ID: 28439555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
    Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
    J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Cholesterol Concentration and Lipid Phase on Structure and Fluctuation of Amyloid Precursor Protein.
    Pantelopulos GA; Panahi A; Straub JE
    J Phys Chem B; 2020 Nov; 124(45):10173-10185. PubMed ID: 33135883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Alzheimer's disease-associated C99 fragment of APP regulates cellular cholesterol trafficking.
    Montesinos J; Pera M; Larrea D; Guardia-Laguarta C; Agrawal RR; Velasco KR; Yun TD; Stavrovskaya IG; Xu Y; Koo SY; Snead AM; Sproul AA; Area-Gomez E
    EMBO J; 2020 Oct; 39(20):e103791. PubMed ID: 32865299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bexarotene Binds to the Amyloid Precursor Protein Transmembrane Domain, Alters Its α-Helical Conformation, and Inhibits γ-Secretase Nonselectively in Liposomes.
    Kamp F; Scheidt HA; Winkler E; Basset G; Heinel H; Hutchison JM; LaPointe LM; Sanders CR; Steiner H; Huster D
    ACS Chem Neurosci; 2018 Jul; 9(7):1702-1713. PubMed ID: 29717863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmembrane fragment structures of amyloid precursor protein depend on membrane surface curvature.
    Dominguez L; Meredith SC; Straub JE; Thirumalai D
    J Am Chem Soc; 2014 Jan; 136(3):854-7. PubMed ID: 24364734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MT5-MMP controls APP and β-CTF/C99 metabolism through proteolytic-dependent and -independent mechanisms relevant for Alzheimer's disease.
    García-González L; Paumier JM; Louis L; Pilat D; Bernard A; Stephan D; Jullien N; Checler F; Nivet E; Khrestchatisky M; Baranger K; Rivera S
    FASEB J; 2021 Jul; 35(7):e21727. PubMed ID: 34117802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substrate determinants in the C99 juxtamembrane domains differentially affect γ-secretase cleavage specificity and modulator pharmacology.
    Ousson S; Saric A; Baguet A; Losberger C; Genoud S; Vilbois F; Permanne B; Hussain I; Beher D
    J Neurochem; 2013 May; 125(4):610-9. PubMed ID: 23253155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid beta-protein generation.
    Xia W; Ray WJ; Ostaszewski BL; Rahmati T; Kimberly WT; Wolfe MS; Zhang J; Goate AM; Selkoe DJ
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9299-304. PubMed ID: 10922078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease mutations in APP but not γ-secretase modulators affect epsilon-cleavage-dependent AICD production.
    Dimitrov M; Alattia JR; Lemmin T; Lehal R; Fligier A; Houacine J; Hussain I; Radtke F; Dal Peraro M; Beher D; Fraering PC
    Nat Commun; 2013; 4():2246. PubMed ID: 23907250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Verteporfin is a substrate-selective γ-secretase inhibitor that binds the amyloid precursor protein transmembrane domain.
    Castro MA; Parson KF; Beg I; Wilkinson MC; Nurmakova K; Levesque I; Voehler MW; Wolfe MS; Ruotolo BT; Sanders CR
    J Biol Chem; 2022 Apr; 298(4):101792. PubMed ID: 35247387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that the amyloid-β protein precursor intracellular domain, AICD, derives from β-secretase-generated C-terminal fragment.
    Flammang B; Pardossi-Piquard R; Sevalle J; Debayle D; Dabert-Gay AS; Thévenet A; Lauritzen I; Checler F
    J Alzheimers Dis; 2012; 30(1):145-53. PubMed ID: 22406447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.